Summary
Item |
Summary |
Project
|
29065883
|
Virus Name
|
HBV |
Sample Number
|
12 |
Disease
|
acute-on-chronic liver failure (ACLF) in chronic hepatitis B (CHB) |
Country
|
China |
Sample
ID |
Sample ID |
Age |
Gender |
Origin |
Detail |
1 |
LF1 |
57 |
F |
China |
View |
2 |
LF2 |
49 |
M |
China |
View |
3 |
LF3 |
21 |
M |
China |
View |
4 |
LF4 |
50 |
M |
China |
View |
5 |
LF5 |
28 |
M |
China |
View |
6 |
LF13 |
39 |
M |
China |
View |
7 |
LF14 |
58 |
M |
China |
View |
8 |
LF15 |
64 |
M |
China |
View |
9 |
LF16 |
56 |
M |
China |
View |
10 |
LF17 |
61 |
M |
China |
View |
11 |
LF18 |
26 |
M |
China |
View |
12 |
LF19 |
54 |
M |
China |
View |
Literature
Item |
Summary |
PMID
|
29065883 |
Title
|
Chronic hepatitis B carriers with acute on chronic liver failure show increased HBV surface gene mutations, including immune escape variants. |
Abstract
|
BACKGROUND: The pathogenesis of acute-on-chronic liver failure (ACLF) in chronic hepatitis B (CHB) is not well understood. The aim of this study was to investigate whether there is an association between HBV polymerase (P)/overlapping surface (S) gene and basal core promoter (BCP)/precore (PC) variants and development of ACLF in CHB. METHODS: Two CHB patient cohorts were compared: (i) ACLF (N = 12) (11/12 M, median age 52 yrs., 5/9 genotype C, 6/12 HBeAg+), (ii) 27 treatment native CHB carriers (15/27 M, median age 44 yrs., 9 genotype B, 10 genotype C, 1 genotype A, 5 genotype D, 2 genotype E). Clonal sequencing of PCR-amplified HBV P/S and BCP/PC gene fragments was done and HBV diversity, frequency of immune escape (IE) and drug resistance (DR) mutations and mutations in BCP/PC gene (G1896A and A1762T/G1764A), were compared between each group. RESULTS: Our data showed the incidence of IE and clusters of mutations in the HBV S region was significantly greater in ACLF patients vs. treatment naive CHB patients (p < 0.05). Additionally, a significantly higher frequency of G1896A and A1762T/G1764A mutations were found in HBeAg negative than in ACLF patients (p < 0.0001). CONCLUSION: In our study, ACLF was not associated with a specific genomic mutation. However, higher frequency of IE mutations along with various mutations clustering in the HBV S region could contribute to or be an outcome of ACLF in CHB infection. (words 226). |
|